Switzerland · Biotechnology startup

VectivBio

VectivBio is a biotechnology company committed to making innovative treatments for patients suffering from serious rare diseases.

Funding reportedLast round: Post ipo equity

BiotechnologyBasel, Switzerland

What company datasets say VectivBio raised

Funding, as reported

Reported in all399Min the source's currency
Rounds5
Last roundPost ipo equity
Last round dateOct 2022
Investors listed18

Founders and team

From VectivBio's own website: 5 on the team.

  • John MinardoSenior Vice President, Chief Legal Officer
  • Thomas McCourtChief Executive Officer
  • Jeff RubertiChief Strategy Officer
  • Ron SilverInterim Chief Financial Officer
  • Tammi GaskinsChief Commercial Officer

Biotechnology in Switzerland

Startups like it

Is this your company?

Add your raise, your deck and your story, and put VectivBio in front of investors. Or tell us what we have wrong.